Is Brainspotting Evidence-Based or Pseudoscience?

Brainspotting has some early clinical research showing positive results, but it is not yet considered an evidence-based therapy by major psychological or medical organizations. It lacks the large-scale randomized controlled trials, systematic reviews, and meta-analyses that therapies like EMDR and cognitive behavioral therapy have accumulated over decades. The research that does exist is promising but limited, and serious scientific critiques have been raised about the theoretical claims behind the technique.

What Brainspotting Actually Is

Brainspotting was developed in 2003 by David Grand, a psychotherapist who had been practicing EMDR (eye movement desensitization and reprocessing). During an EMDR session, he noticed that a client’s eyes seemed to wobble at a specific point in their visual field, and that holding that gaze position appeared to unlock deeper emotional processing. He built an entire therapeutic framework around the idea that specific eye positions correspond to stored emotional and traumatic material in the brain.

In a typical session, a therapist slowly guides a pointer across your field of vision while you focus on a distressing memory or body sensation. When you notice a spike in emotional intensity or a physical reflex (like an eye twitch or sudden tension), the therapist holds the pointer there. You then maintain your gaze on that “brainspot” while processing whatever comes up. Sessions usually last 60 to 90 minutes, and many therapists recommend 6 to 10 sessions as a starting point. Some people report feeling shifts after just a few sessions, while others need longer-term work.

What the Clinical Research Shows

The most cited study comparing brainspotting to other approaches was published in the International Journal of Environmental Research and Public Health. Researchers tested single sessions of brainspotting, EMDR, and body scan meditation on participants processing distressing memories. Both brainspotting and EMDR produced significant reductions in distress scores from before to after the session, and those improvements held at follow-up. Body scan meditation did not perform as well.

The key finding: brainspotting and EMDR produced statistically equivalent results. Distress scores after EMDR were slightly lower numerically, but the difference was not statistically significant. Both techniques also changed how participants told the story of their distressing memory. After brainspotting or EMDR, people described their memories more concisely, a sign that emotional processing had occurred. This shift did not happen with body scan meditation.

Patient preferences were split. Some participants preferred brainspotting because they felt freer during the process, with less structure imposed by the therapist. Others said they felt “a little bit lost” during brainspotting and preferred the more guided approach of EMDR. This is worth knowing if you’re choosing between the two: brainspotting is less directive, which can feel either liberating or unmoored depending on your temperament.

That said, one comparative study with single sessions does not constitute a robust evidence base. There are no large randomized controlled trials, no published systematic reviews, and no meta-analyses calculating effect sizes for brainspotting across multiple studies. For comparison, EMDR has been evaluated in dozens of randomized trials and is recognized as an effective trauma treatment by the World Health Organization and the American Psychological Association. Brainspotting has nothing close to that volume of research.

The Theoretical Claims and Their Critics

Brainspotting’s central premise is that where you look affects how you access stored trauma. The idea draws on real neuroscience: the amygdala, a brain structure involved in threat detection and emotional memory, is genuinely involved in processing gaze. Research confirms the amygdala activates during gaze monitoring tasks and functions as part of a vigilance system that analyzes sensory input for emotionally significant information.

The problem is the leap from that general neuroscience to brainspotting’s specific claims. A paper published in Medical Hypotheses examined brainspotting’s theoretical framework and concluded that its developers “laid out a sequence of brain areas that appear plausible in relation to trauma, despite the complete absence of any available evidence for their assertions.” The critique is pointed: brainspotting describes mechanisms of action that sound grounded in science but, on close inspection, are not consistent with the available research. The paper went further, arguing that brainspotting “fully meets the criteria for a pseudoscience” due to its lack of empirical support combined with scientific-sounding but unverified claims about how it works.

This is an important distinction. A therapy can produce real benefits for real reasons that are different from the ones its creators propose. Many people feel better after brainspotting sessions, but that improvement might come from the focused attention, the therapeutic relationship, the sustained mindfulness-like state, or other nonspecific factors rather than from the “brainspot” mechanism itself. Without studies that isolate the specific eye-position component, it’s impossible to know whether that element is doing the therapeutic heavy lifting or is incidental.

How It Compares to Established Therapies

EMDR is the closest comparison point. Both therapies use eye-related techniques to process traumatic memories, and in the one head-to-head study available, they performed similarly. But their evidence bases are vastly different. EMDR has been studied for over 30 years, has strong guideline endorsements, and is recommended as a first-line treatment for PTSD by multiple international health authorities. Brainspotting has none of these endorsements.

Cognitive behavioral therapy and prolonged exposure therapy also have far more extensive research support for trauma, anxiety, and depression. If you’re evaluating brainspotting against these options, the honest picture is that brainspotting shows early promise but has not been tested rigorously enough to be ranked alongside them.

Who Practices It

Brainspotting has grown substantially since 2003. Thousands of clinicians worldwide have completed training. Certification requires completing multiple training phases, documenting at least 50 brainspotting sessions, and completing a minimum of 6 hours of consultation with an approved consultant. Practitioners are expected to hold a professional license or describe their healing practice if licensure doesn’t apply. New certification standards take effect in November 2025.

The training structure is organized but entirely self-governed by Brainspotting Trainings, LLC. There is no external accreditation from a psychological or medical board. This is common for newer therapeutic modalities but worth understanding: certification reflects completion of a training program, not validation by an independent scientific body.

What This Means If You’re Considering It

Brainspotting sits in a gray zone. It is not evidence-based in the way that term is used in clinical psychology, where it means a therapy has been tested in multiple rigorous trials and recognized in treatment guidelines. But it is also not without any research support. The available studies suggest it can reduce distress related to difficult memories, and it performs comparably to EMDR in limited testing.

If you’re drawn to brainspotting, the most reasonable approach is to view it as a therapy with preliminary support rather than proven effectiveness. People who have tried both brainspotting and EMDR sometimes prefer one over the other based on how much structure they want in a session. Brainspotting’s less directive style appeals to some and feels disorienting to others. Your comfort with the process matters, because engagement with any therapy is one of the strongest predictors of whether it helps.

The honest bottom line: brainspotting may work, but science hasn’t yet confirmed why it works, whether the eye-position mechanism is the active ingredient, or how it performs across large and diverse populations over time.